 | • レポートコード：B-GIR09F3116 • 出版社/出版日：GlobalInfoResearch / 2019年9月13日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、イバンドロネートの世界市場について調べ、まとめました。種類別セグメントは、経口、注射等、用途別セグメントは、病院、薬局等に区分しました。イバンドロネートの世界市場概観、企業動向、企業別イバンドロネートシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・イバンドロネートの市場概観 ・イバンドロネートの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・イバンドロネートの企業別販売動向、市場シェア、市場集中度、競争動向 ・イバンドロネートの世界市場規模 ・イバンドロネートの北米市場分析（アメリカ、カナダ、メキシコ等） ・イバンドロネートのアメリカ市場規模推移 ・イバンドロネートのカナダ市場規模推移 ・イバンドロネートのメキシコ市場規模推移 ・イバンドロネートのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・イバンドロネートのドイツ市場規模推移 ・イバンドロネートのイギリス市場規模推移 ・イバンドロネートのロシア市場規模推移 ・イバンドロネートのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・イバンドロネートの日本市場規模推移 ・イバンドロネートの中国市場規模推移 ・イバンドロネートの韓国市場規模推移 ・イバンドロネートのインド市場規模推移 ・イバンドロネートの東南アジア市場規模推移 ・イバンドロネートの南米市場分析（ブラジル、アルゼンチン等） ・イバンドロネートの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・イバンドロネートの種類別分析/販売量、売上、市場シェア（経口、注射） ・イバンドロネートの用途別分析/市場規模（病院、薬局） ・イバンドロネートの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・イバンドロネートの販売チャネル・代理店・貿易業者・ディーラー分析 |
Ibandronate is prescription medication used for treating osteoporosis in women after menopause.
Scope of the Report:
The global Ibandronate market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Ibandronate.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Ibandronate market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Ibandronate market by product type and applications/end industries.
Market Segment by Companies, this report covers
Roche
Apotex
Mylan
Sun Pharmaceutical
Dr Reddy’s Laboratories
Aurobindo Pharma
MACLEODS
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral
Injection
Market Segment by Applications, can be divided into
Hospital
Drug store
Table of Contents
1 Ibandronate Market Overview
1.1 Product Overview and Scope of Ibandronate
1.2 Classification of Ibandronate by Types
1.2.1 Global Ibandronate Revenue Comparison by Types (2019-2024)
1.2.2 Global Ibandronate Revenue Market Share by Types in 2018
1.2.3 Oral
1.2.4 Injection
1.3 Global Ibandronate Market by Application
1.3.1 Global Ibandronate Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Ibandronate Market by Regions
1.4.1 Global Ibandronate Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Ibandronate Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Ibandronate Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Ibandronate Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Ibandronate Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Ibandronate Status and Prospect (2014-2024)
1.5 Global Market Size of Ibandronate (2014-2024)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Ibandronate Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Ibandronate Revenue, Gross Margin and Market Share (2017-2018)
2.2 Apotex
2.2.1 Business Overview
2.2.2 Ibandronate Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Apotex Ibandronate Revenue, Gross Margin and Market Share (2017-2018)
2.3 Mylan
2.3.1 Business Overview
2.3.2 Ibandronate Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Mylan Ibandronate Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sun Pharmaceutical
2.4.1 Business Overview
2.4.2 Ibandronate Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sun Pharmaceutical Ibandronate Revenue, Gross Margin and Market Share (2017-2018)
2.5 Dr Reddy’s Laboratories
2.5.1 Business Overview
2.5.2 Ibandronate Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Dr Reddy’s Laboratories Ibandronate Revenue, Gross Margin and Market Share (2017-2018)
2.6 Aurobindo Pharma
2.6.1 Business Overview
2.6.2 Ibandronate Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Aurobindo Pharma Ibandronate Revenue, Gross Margin and Market Share (2017-2018)
2.7 MACLEODS
2.7.1 Business Overview
2.7.2 Ibandronate Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 MACLEODS Ibandronate Revenue, Gross Margin and Market Share (2017-2018)
3 Global Ibandronate Market Competition, by Players
3.1 Global Ibandronate Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Ibandronate Players Market Share
3.2.2 Top 10 Ibandronate Players Market Share
3.3 Market Competition Trend
4 Global Ibandronate Market Size by Regions
4.1 Global Ibandronate Revenue and Market Share by Regions
4.2 North America Ibandronate Revenue and Growth Rate (2014-2019)
4.3 Europe Ibandronate Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Ibandronate Revenue and Growth Rate (2014-2019)
4.5 South America Ibandronate Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Ibandronate Revenue and Growth Rate (2014-2019)
5 North America Ibandronate Revenue by Countries
5.1 North America Ibandronate Revenue by Countries (2014-2019)
5.2 USA Ibandronate Revenue and Growth Rate (2014-2019)
5.3 Canada Ibandronate Revenue and Growth Rate (2014-2019)
5.4 Mexico Ibandronate Revenue and Growth Rate (2014-2019)
6 Europe Ibandronate Revenue by Countries
6.1 Europe Ibandronate Revenue by Countries (2014-2019)
6.2 Germany Ibandronate Revenue and Growth Rate (2014-2019)
6.3 UK Ibandronate Revenue and Growth Rate (2014-2019)
6.4 France Ibandronate Revenue and Growth Rate (2014-2019)
6.5 Russia Ibandronate Revenue and Growth Rate (2014-2019)
6.6 Italy Ibandronate Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Ibandronate Revenue by Countries
7.1 Asia-Pacific Ibandronate Revenue by Countries (2014-2019)
7.2 China Ibandronate Revenue and Growth Rate (2014-2019)
7.3 Japan Ibandronate Revenue and Growth Rate (2014-2019)
7.4 Korea Ibandronate Revenue and Growth Rate (2014-2019)
7.5 India Ibandronate Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Ibandronate Revenue and Growth Rate (2014-2019)
8 South America Ibandronate Revenue by Countries
8.1 South America Ibandronate Revenue by Countries (2014-2019)
8.2 Brazil Ibandronate Revenue and Growth Rate (2014-2019)
8.3 Argentina Ibandronate Revenue and Growth Rate (2014-2019)
8.4 Colombia Ibandronate Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Ibandronate by Countries
9.1 Middle East and Africa Ibandronate Revenue by Countries (2014-2019)
9.2 Saudi Arabia Ibandronate Revenue and Growth Rate (2014-2019)
9.3 UAE Ibandronate Revenue and Growth Rate (2014-2019)
9.4 Egypt Ibandronate Revenue and Growth Rate (2014-2019)
9.5 Nigeria Ibandronate Revenue and Growth Rate (2014-2019)
9.6 South Africa Ibandronate Revenue and Growth Rate (2014-2019)
10 Global Ibandronate Market Segment by Type
10.1 Global Ibandronate Revenue and Market Share by Type (2014-2019)
10.2 Global Ibandronate Market Forecast by Type (2019-2024)
10.3 Oral Revenue Growth Rate (2014-2024)
10.4 Injection Revenue Growth Rate (2014-2024)
11 Global Ibandronate Market Segment by Application
11.1 Global Ibandronate Revenue Market Share by Application (2014-2019)
11.2 Ibandronate Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Drug store Revenue Growth (2014-2019)
12 Global Ibandronate Market Size Forecast (2019-2024)
12.1 Global Ibandronate Market Size Forecast (2019-2024)
12.2 Global Ibandronate Market Forecast by Regions (2019-2024)
12.3 North America Ibandronate Revenue Market Forecast (2019-2024)
12.4 Europe Ibandronate Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Ibandronate Revenue Market Forecast (2019-2024)
12.6 South America Ibandronate Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Ibandronate Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Ibandronate Picture
Table Product Specifications of Ibandronate
Table Global Ibandronate and Revenue (Million USD) Market Split by Product Type
Figure Global Ibandronate Revenue Market Share by Types in 2018
Figure Oral Picture
Figure Injection Picture
Table Global Ibandronate Revenue (Million USD) by Application (2014-2024)
Figure Ibandronate Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Drug store Picture
Table Global Market Ibandronate Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Ibandronate Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Ibandronate Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Ibandronate Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Ibandronate Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Ibandronate Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Ibandronate Revenue (Million USD) and Growth Rate (2014-2024)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Ibandronate Type and Applications
Table Roche Ibandronate Revenue, Gross Margin and Market Share (2017-2018)
Table Apotex Basic Information, Manufacturing Base and Competitors
Table Apotex Ibandronate Type and Applications
Table Apotex Ibandronate Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Ibandronate Type and Applications
Table Mylan Ibandronate Revenue, Gross Margin and Market Share (2017-2018)
Table Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Sun Pharmaceutical Ibandronate Type and Applications
Table Sun Pharmaceutical Ibandronate Revenue, Gross Margin and Market Share (2017-2018)
Table Dr Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table Dr Reddy's Laboratories Ibandronate Type and Applications
Table Dr Reddy's Laboratories Ibandronate Revenue, Gross Margin and Market Share (2017-2018)
Table Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table Aurobindo Pharma Ibandronate Type and Applications
Table Aurobindo Pharma Ibandronate Revenue, Gross Margin and Market Share (2017-2018)
Table MACLEODS Basic Information, Manufacturing Base and Competitors
Table MACLEODS Ibandronate Type and Applications
Table MACLEODS Ibandronate Revenue, Gross Margin and Market Share (2017-2018)
Table Global Ibandronate Revenue (Million USD) by Players (2014-2019)
Table Global Ibandronate Revenue Share by Players (2014-2019)
Figure Global Ibandronate Revenue Share by Players in 2017
Figure Global Ibandronate Revenue Share by Players in 2018
Figure Global Top 5 Players Ibandronate Revenue Market Share in 2018
Figure Global Top 10 Players Ibandronate Revenue Market Share in 2018
Figure Global Ibandronate Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Ibandronate Revenue (Million USD) by Regions (2014-2019)
Table Global Ibandronate Revenue Market Share by Regions (2014-2019)
Figure Global Ibandronate Revenue Market Share by Regions (2014-2019)
Figure Global Ibandronate Revenue Market Share by Regions in 2018
Figure North America Ibandronate Revenue and Growth Rate (2014-2019)
Figure Europe Ibandronate Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Ibandronate Revenue and Growth Rate (2014-2019)
Figure South America Ibandronate Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Ibandronate Revenue and Growth Rate (2014-2019)
Table North America Ibandronate Revenue by Countries (2014-2019)
Table North America Ibandronate Revenue Market Share by Countries (2014-2019)
Figure North America Ibandronate Revenue Market Share by Countries (2014-2019)
Figure North America Ibandronate Revenue Market Share by Countries in 2018
Figure USA Ibandronate Revenue and Growth Rate (2014-2019)
Figure Canada Ibandronate Revenue and Growth Rate (2014-2019)
Figure Mexico Ibandronate Revenue and Growth Rate (2014-2019)
Table Europe Ibandronate Revenue (Million USD) by Countries (2014-2019)
Figure Europe Ibandronate Revenue Market Share by Countries (2014-2019)
Figure Europe Ibandronate Revenue Market Share by Countries in 2018
Figure Germany Ibandronate Revenue and Growth Rate (2014-2019)
Figure UK Ibandronate Revenue and Growth Rate (2014-2019)
Figure France Ibandronate Revenue and Growth Rate (2014-2019)
Figure Russia Ibandronate Revenue and Growth Rate (2014-2019)
Figure Italy Ibandronate Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Ibandronate Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Ibandronate Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Ibandronate Revenue Market Share by Countries in 2018
Figure China Ibandronate Revenue and Growth Rate (2014-2019)
Figure Japan Ibandronate Revenue and Growth Rate (2014-2019)
Figure Korea Ibandronate Revenue and Growth Rate (2014-2019)
Figure India Ibandronate Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Ibandronate Revenue and Growth Rate (2014-2019)
Table South America Ibandronate Revenue by Countries (2014-2019)
Table South America Ibandronate Revenue Market Share by Countries (2014-2019)
Figure South America Ibandronate Revenue Market Share by Countries (2014-2019)
Figure South America Ibandronate Revenue Market Share by Countries in 2018
Figure Brazil Ibandronate Revenue and Growth Rate (2014-2019)
Figure Argentina Ibandronate Revenue and Growth Rate (2014-2019)
Figure Colombia Ibandronate Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Ibandronate Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Ibandronate Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Ibandronate Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Ibandronate Revenue Market Share by Countries in 2018
Figure Saudi Arabia Ibandronate Revenue and Growth Rate (2014-2019)
Figure UAE Ibandronate Revenue and Growth Rate (2014-2019)
Figure Egypt Ibandronate Revenue and Growth Rate (2014-2019)
Figure Nigeria Ibandronate Revenue and Growth Rate (2014-2019)
Figure South Africa Ibandronate Revenue and Growth Rate (2014-2019)
Table Global Ibandronate Revenue (Million USD) by Type (2014-2019)
Table Global Ibandronate Revenue Share by Type (2014-2019)
Figure Global Ibandronate Revenue Share by Type (2014-2019)
Figure Global Ibandronate Revenue Share by Type in 2019
Table Global Ibandronate Revenue Forecast by Type (2019-2024)
Figure Global Ibandronate Market Share Forecast by Type (2019-2024)
Figure Global Oral Revenue Growth Rate (2014-2019)
Figure Global Injection Revenue Growth Rate (2014-2019)
Table Global Ibandronate Revenue by Application (2014-2019)
Table Global Ibandronate Revenue Share by Application (2014-2019)
Figure Global Ibandronate Revenue Share by Application (2014-2019)
Figure Global Ibandronate Revenue Share by Application in 2019
Table Global Ibandronate Revenue Forecast by Application (2019-2024)
Figure Global Ibandronate Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Drug store Revenue Growth Rate (2014-2019)
Figure Global Ibandronate Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Ibandronate Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Ibandronate Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Ibandronate Revenue Market Forecast (2019-2024)
Figure Europe Ibandronate Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Ibandronate Revenue Market Forecast (2019-2024)
Figure South America Ibandronate Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Ibandronate Revenue Market Forecast (2019-2024)
世界のビスホスホネート市場予測（～2024年） Bisphosphonates are a drugs that treat bone problems, such as thin or fragile bones. Bisphosphonates are enzyme-resistant analogues of pyrophosphate, which normally inhibits mineralization in the bone. Their effect is dose dependent and they reduce the turnover of bone by inhibiting recruitment and …- 世界のアンブリセンタン薬市場予測（～2024年）：企業別、地域別、種類・用途別 Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension. Scope of the Report: The global Ambrisentan Drug market is valued at xx million USD in 2018 and is expected to reach xx mil…
- 世界のデシタビン薬市場予測（～2024年）：企業別、地域別、種類・用途別 Decitabine (trade name Dacogen), or 5-aza-2'-deoxycytidine, acts as an Nucleic Acid Synthesis Inhibitor. It is a drug for the treatment of myelodysplastic syndromes, a class of conditions where certain blood cells are dysfunctional, and for acute myeloid leukemia (AML). Scope of the Report: The glob…
- 世界のシクロベンザプリン薬市場予測（～2024年）：企業別、地域別、種類・用途別 Cyclobenzaprine is used with rest, physical therapy, and other measures to relax muscles and relieve pain and discomfort caused by strains, sprains, and other muscle injuries. Cyclobenzaprine is in a class of medications called skeletal muscle relaxants. It works by acting in the brain and nervous s…
- 世界のティプラナビル市場予測（～2024年）：企業別、地域別、種類・用途別 Tipranavir (TPV), or tipranavir disodium, is a nonpeptidic protease inhibitor (PI) manufactured by Boehringer Ingelheim under the trade name Aptivus. It is administered with ritonavir in combination therapy to treat HIV infection. Scope of the Report: The global Tipranavir market is valued at xx mil…